Clover Health Investments Corp expected to post a loss of 7 cents a share - Earnings Preview

Clover Health Investments

04/05/2024 01:15

* Clover Health Investments Corp  CLOV.OQ   CLOV.O  is
expected
to show a fall in quarterly revenue when it reports  results on
May 7 for the period ending March 31 2024
    * The Franklin Tennessee-based  company is expected to
report a
39.1% decrease in revenue to $321.226 million from $527.78
million a year ago, according to the mean estimate from 3
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Clover Health
Investments Corp
is for a loss of 7 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Clover
Health
Investments Corp is $1.38​, above​ its last closing price
of $0.70. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.10       -0.14      -0.14     Met     -0.5
 Sep. 30 2023  -0.10       -0.11      -0.09     Beat    14.8
 Jun. 30 2023  -0.15       -0.15      -0.06     Beat    60.1​
 Mar. 31 2023  -0.17       -0.18      -0.15     Beat    14.7
 ​​Dec.        -0.23       -0.26      -0.17     Beat    31.4
 31 2022                                                
 Sep. 30 2022  -0.25       -0.24      -0.16     Beat    33.1​
 Jun. 30 2022  -0.21       -0.21      -0.22     Missed  -6.7
 Mar. 31 2022  -0.28       -0.27      -0.19     Beat    30.5
 This summary was machine generated May 4 at 00:15 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)